Neuraceq Injection, Solution
Product Images NDC 54828-001

6 FDA label images from Lantheus Biosciences Ltd., A Lantheus Company · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Neuraceq (NDC 54828-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lantheus Biosciences Ltd., A Lantheus Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure (Figure)

Figure (Figure)
Illustrative brain scan images comparing Neuraceq (Florbetaben F 18) negative and positive scans. The top row shows negative scans, and the bottom row shows positive scans, across the cerebellum, lateral temporal lobes, frontal lobes, posterior cingulate/precuneus, and parietal lobes. Yellow arrows and dashed lines highlight regions of interest in each brain section.*
FDA Label Image

Shield Label Nm 06 2022 Fda Approved Lmi

Shield Label Nm 06 2022 Fda Approved Lmi
Label for Neuraceq (Florbetaben F 18) injection, solution for intravenous use. The label indicates a 50 mL multiple-dose vial containing 135 mCi/mL strength. It includes caution marking for radioactive material and instructions about dosage, storage, and expiration. Labeler is Lantheus Biosciences Ltd.*
FDA Label Image

Shield Label Sofie 06 2022 Fda Approved Lmi

Shield Label Sofie 06 2022 Fda Approved Lmi
Label for Neuraceq (Florbetaben F 18) injection, solution for intravenous use. The label indicates a 50 mL multiple-dose vial containing Florbetaben F 18 at 135 mCi/mL. It includes cautionary information about radioactive material, expiration instructions, and storage conditions. Labeler is Lantheus Biosciences Ltd.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Florbetaben F 18 shown as a molecular diagram with aromatic rings, ether linkages, and a fluorine-18 atom at one end, corresponding to the active ingredient in Neuraceq injection solution.*
FDA Label Image

Vial Label Nm 06 2022 Fda Approved Lmi

Vial Label Nm 06 2022 Fda Approved Lmi
Label for Neuraceq (Florbetaben F 18) injection, solution for intravenous use, 135 mCi/mL strength. It is a 50 mL multiple-dose vial labeled Rx only and contains radioactive material. The label includes dosage activity details, storage instructions, and a caution symbol indicating the radioactive nature of the product. Manufactured by Lantheus Biosciences Ltd.*
FDA Label Image

Vial Label Sofie 06 2022 Fda Approved Lmi

Vial Label Sofie 06 2022 Fda Approved Lmi
Neuraceq Florbetaben F 18 injection, 135 mCi/mL, 50 mL multiple-dose vial label. It includes dosing information, expiration details, and a radioactive material caution symbol. The label indicates intravenous use and is labeled by Lantheus Biosciences Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.